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The present study was designed to investigate an association of common -588C/T and
-23G/T polymorphisms within glutamate cysteine ligase modifier subunit gene with
susceptibility to bronchial asthma. A total of 435 ethnically Russian subjects were
recruited in this study, including 221 patients with asthma and 214 sex and age matched
healthy subjects. As previously reported, the -588C/T and -23G/T polymorphisms were
completely linked. The -588TT/-23TT genotype was found to be associated with decreased
risk of allergic asthma after adjustment for age, gender and smoking status using
multivariate logistic regression analysis (OR ¼ 0.33 95% CI 0.15–0.70, p ¼ 0.036). However,
the -588CT/-23GT genotype was associated with increased risk of non-allergic asthma
(OR ¼ 2.03 95% CI 1.05–3.90, p ¼ 0.06). This is a first study reporting the association
between genetic variations in the glutamate cysteine ligase gene and susceptibility to
bronchial asthma.
& 2007 Elsevier Ltd. All rights reserved.Introduction
An accumulating body of evidence indicates that imbalances
in oxidant–antioxidant systems may play a role in theElsevier Ltd. All rights reserved.
4712 58 81 47.
.ru (A.V. Polonikov).pathogenesis of bronchial asthma.1–3 As oxidative stress may
be involved in mechanisms causing asthma, polymorphic
genes encoding for antioxidant defense enzymes may be
putative candidates for genetic susceptibility to the disease.
Despite the importance of this question, existing data on the
impact of genetic polymorphisms of these enzymes on the
development of asthma are surprisingly limited.4–6 In the
present study, we have investigated, for the first time,
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Glutamate cysteine ligase gene and asthma 2423whether common polymorphisms -588C/T and -23G/T in the
50-flanking region of glutamate cysteine ligase modifier
(GCLM) subunit gene, the rate-limiting enzyme for glu-
tathione (GSH) synthesis, are associated with genetic
susceptibility to bronchial asthma.Methods
A total of 435 subjects were recruited into this study,
including 221 patients with asthma (97 males and 124
females) and 214 healthy subjects (92 males and 122
females). All study subjects were of Russian origin from
Central Russia. The mean age of the asthmatics was 44.7
years (range: 16–69), the mean age of the healthy subjects
was 41.3 years (range: 17–84). The study groups did not
differ in percent of smokers (29.9% in patients vs. 26.6% in
controls, p40.05). The study was approved by an Ethical
Review Committee of Kursk State Medical University and the
subjects who were recruited gave informed consent. All
asthmatics were recruited by the Department of Pulmonol-
ogy in Kursk Regional Clinical Hospital during 2003–04. All
patients were diagnosed with asthma by the presence of
characteristic symptoms, reversibility of airway obstructionTable 1 Distribution of alleles and genotypes of polymorphis
bronchial asthma and healthy subjects.
GCLM allele and genotype frequencies Asthmatics n (%)y Co
Asthma, entire group (n ¼ 221)
Allele frequencies
-588C/-23G allele 0.765 0.
-588T/-23T allele 0.235 0.
Genotype frequencies
-588CC/-23GG genotype 120 (54.3) 12
-588CT/-23GT genotype 98 (44.3) 78
-588TT/-23TT genotype 3 (1.4) 16
Allergic asthma (n ¼ 161)
Allele frequencies
-588C/-23G allele 0.776 0.
-588T/-23T allele 0.224 0.
Genotype frequencies
-588CC/-23GG genotype 92 (57.1) 12
-588CT/-23GT genotype 66 (41.0) 78
-588TT/-23TT genotype 3 (1.9) 16
Non-allergic asthma (n ¼ 57)
Allele frequencies
-588C/-23G allele 0.728 0.
-588T/-23T allele 0.272 0.
Genotype frequencies
-588CC/-23GG genotype 26 (45.6) 12
-588CT/-23GT genotype 31 (54.4) 78
-588TT/-23TT genotype 0 (0.0) 16
yAbsolute number and percentage of individuals with particular ge
zw2 statistics with Yates’ correction and p-values (d.f. ¼ 1).
yOdds ratio adjusted for age, gender and smoking status with 95%
p-Values with the Bonferroni correction for multiple comparisonsor airway hyperresponsiveness to methacholine. Skin prick
testing and total serum IgE levels were determined in all
study participants. Asthmatics who showed either negative
skin prick test (o5mm) or a normal total IgE (o0.35 IU)
were considered as patients with non-allergic asthma. DNA
samples from study subjects were analyzed for -588C/T
(rs41303970) and -23G/T (rs743119) polymorphisms in the
GCLM gene by polymerase chain reaction followed by
restriction fragment length polymorphism analyses as
reported by Nakamura et al.7 The genotyping results were
scored by two independent investigators who did not know
whether the sample was from a case patient or a control.
Statistical calculations were performed with Statistica for
Windows 6.0 (StatSoft Inc., Tulsa, OK, USA).Results
The observed genotype frequencies of the GCLM gene in
healthy group were in Hardy–Weinberg equilibrium. A
significant deviation of GCLM genotype frequencies from
Hardy–Weinberg equilibrium was observed in asthmatics
(po0.001). The genotype distribution and allele frequencies
for -588C/T and -23G/T polymorphisms of the GCLM genems -588C/T and -23G/T of the GCLM gene in patients with
ntrols (n ¼ 214) n (%)y w2 (p)z OR (95% CI)y
743 0.55 0.89
257 (0.46) (0.65–1.21)
0 (56.1) 0.14 (0.71) 1.04 (0.68–1.59)
(36.4) 2.81 (0.09) 1.30 (0.84–2.01)
(7.5) 8.34 (0.0081) 0.33 (0.15–0.70)
743 1.12 0.83
257 (0.29) (0.59–1.17)
0 (56.1) 0.04 (0.84) 1.27 (0.79–2.04)
(36.4) 0.80 (0.37) 1.04 (0.64–1.68)
(7.5) 4.91 (0.036) 0.40 (0.19–0.87)
743 0.10 1.08
257 (0.75) (0.68–1.72)
0 (56.1) 1.98 (0.16) 0.72 (0.38–1.38)
(36.4) 6.02 (0.06) 2.03 (1.05–3.90)
(7.5) 3.28 (0.14) 0.10 (0.01–1.74)
notype.
confidence intervals.
.
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A.V. Polonikov et al.2424are listed in Table 1. As can be seen from Table 1, -588C/T
and -23G/T polymorphisms were completely linked. The
frequency of -588TT/-23TT genotype was greater among
healthy subjects (7.5%) than among asthmatics (1.4%). This
association remained significant after adjustment for age,
gender and smoking status using multivariate logistic
regression analysis (OR ¼ 0.33 95% CI 0.15–0.70). Interest-
ingly, a -588TT/-23TT genotype was only found to be
associated with decreased risk of allergic asthma
(OR ¼ 0.40 95% CI 0.19–0.87). The frequency of -588CT/
-23GT genotype was higher in patients with non-allergic
asthma than in healthy controls (OR ¼ 2.03 95% CI
1.05–3.90). However, the latter did not reach statistical
significance after the Bonferroni correction for multiple
comparisons (p ¼ 0.06).Discussion
Glutathione is known as major and naturally occurring
antioxidant, which plays a key role in the control of pro-
inflammatory processes and immune modulation in the
lungs, and it has a predominant role in the regulation of
intracellular redox state and protects airway cells from
oxidative stress.8,9 When airway cells are exposed to
oxidative stress induced by cigarette smoke/air particu-
lates, GSH synthesis is increased through upregulation of
GCLM gene expression, providing a protective mechanism
against free radical-mediated lung injury and inflamma-
tion.8,9
In the present study, we found that -588C/T and -23G/T
polymorphisms in the GCLM gene may be a part of the
genetic predisposition to asthma. A -588CT/-23GT genotype
was found to be associated with increased risk of non-
allergic asthma. It is known7 that variant -588Tallele but not
-23Tallele suppresses oxidant-induced upregulation of GCLM
gene expression and is associated with lower plasma GSH
levels. Thus, the -588T allele may possibly weaken the
intracellular production of GSH in response to oxidative
stress, leading to the increase in susceptibility to the
oxidant-induced lung injury that is thought to occur as part
of the pathogenesis of asthma. In contrast, we observed that
a -588TT/-23TT genotype was associated with decreased
risk of allergic asthma. Unfortunately, no data on the GCLM
gene expression profile in carriers of -588TT genotype are
available in order to explain a possible reason of this
association.In conclusion, we have identified, for the first time, that
-588C/Tand -23G/T polymorphisms in the 50-flanking region
of GCLM gene are associated with asthmatic phenotype,
suggesting that such polymorphisms represent novel genetic
markers able to identify subjects prone to the development
of asthma. However, further investigations are required to
confirm the contribution of these polymorphisms to the risk
of asthma and to assess the relationships between GCLM
genotypes and GCLM expression/activity. A better under-
standing of the genetic mechanisms contributing to an
imbalance between oxidants and antioxidants in the lungs
will provide more effective genotype-based therapeutic and
prophylactic strategies, and will extend access to new drug
targets for therapy of asthma in the future.
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